Piperacillin and Tazobactam for Injection — Class I drug recall D-806-2013
Terminated recall by Apotex Corp., reported 2013-07-24, distributed nationwide. Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.
| Recall number | D-806-2013 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Apotex Corp., Weston, FL, United States |
| Recall initiated | 2013-03-18 |
| Classified | 2013-07-17 |
| Reported by FDA | 2013-07-24 |
| Terminated | 2018-01-08 |
| Distributed | Nationwide (US) |
| Quantity | 37,303 vials |
| NDC | 60505-0773-00 |
| Lot numbers | 01/14, 04/13, 04/14, 07/13, 08/13, 09/13, 12/13, 503B015, 503B016, 503B019, 503B020, 503B021, 503B022, 503B024, 503B025, 503B026, 503B027, 503C005, 503C006, 503C007, 503C008, 503C018 |
Product
Piperacillin and Tazobactam for Injection, USP, 40.5 grams per Pharmacy Bulk Package vial, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd., Irungattukottai - 602 105, India; Mfg. for: Apotex Corp., Weston, FL 33326, NDC 60505-0773-0.
Reason for recall
Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-806-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.